N-terminal domain of SARS CoV-2 spike protein mutation associated reduction in effectivity of neutralizing antibody with vaccinated individuals

J Med Virol. 2021 Oct;93(10):5726-5728. doi: 10.1002/jmv.27181. Epub 2021 Jul 14.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Neutralizing / immunology
  • Antibodies, Neutralizing / therapeutic use*
  • COVID-19 / immunology
  • COVID-19 / therapy*
  • COVID-19 / virology
  • COVID-19 Vaccines / administration & dosage
  • COVID-19 Vaccines / immunology
  • Humans
  • Immunity, Cellular
  • Mutation
  • Protein Domains
  • SARS-CoV-2 / genetics*
  • SARS-CoV-2 / immunology
  • Spike Glycoprotein, Coronavirus / genetics*
  • Spike Glycoprotein, Coronavirus / immunology
  • T-Lymphocytes / immunology

Substances

  • Antibodies, Neutralizing
  • COVID-19 Vaccines
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2